Literature DB >> 8784302

Onychomycosis: a significant medical disorder.

R K Scher1.   

Abstract

A number of factors have contributed to the growing incidence of fungal nail infections, including an aging population, an expanding number of immunocompromised patients, and increasing participation in fitness-related activities. Although onychomycosis and other nail diseases can adversely affect the appearance of the nail unit, the impact of such nail disfigurement extends well beyond the aesthetic realm. In fact, many patients with fungal nail infections experience serious physical, psychosocial, and occupational effects as a result of this disease. In addition, onychomycosis is a serious health burden, particularly in older persons, and has a major economic impact on the healthcare system.

Entities:  

Mesh:

Year:  1996        PMID: 8784302     DOI: 10.1016/s0190-9622(96)90061-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  31 in total

Review 1.  Onychomycosis in the elderly.

Authors:  A K Gupta
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

2.  A health-related quality of life measure for use in patients with onychomycosis: a validation study.

Authors:  D P Lubeck; D Gause; J R Schein; L E Prebil; L P Potter
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

3.  A study on clinico-mycological profile, aetiological agents and diagnosis of onychomycosis at a government medical college hospital in kashmir.

Authors:  Rubeena Lone; Deeba Bashir; Shabir Ahmad; Arshi Syed; Syed Khurshid
Journal:  J Clin Diagn Res       Date:  2013-09-10

4.  Cost of treatment for onychomycosis. Data from a 9-month observational study.

Authors:  D M Stier; C Henke; J Schein; J Doyle; W H Schonfeld; J Broering
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 5.  Pharmacokinetics of antifungal agents in onychomycoses.

Authors:  D Debruyne; A Coquerel
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 6.  Onychomycosis: Practical Approaches to Minimize Relapse and Recurrence.

Authors:  Antonella Tosti; Boni E Elewski
Journal:  Skin Appendage Disord       Date:  2016-09-14

Review 7.  Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.

Authors:  V N Joish; E P Armstrong
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 8.  Patient-Reported Outcomes in Onychomycosis: A Review of Psychometrically Evaluated Instruments in Assessing Treatment Effectiveness.

Authors:  Jenny Wang; Lauren E Wiznia; Evan A Rieder
Journal:  Skin Appendage Disord       Date:  2017-04-21

9.  Treatment of onychomycosis with efinaconazole 10% topical solution and quality of life.

Authors:  Antonella Tosti; Bom E Elewski
Journal:  J Clin Aesthet Dermatol       Date:  2014-11

10.  Onychomycosis in São Paulo, Brazil.

Authors:  Patricio Godoy-Martinez; Fabiane G Nunes; Jane Tomimori-Yamashita; Milton Urrutia; Luis Zaror; Victor Silva; Olga Fischman
Journal:  Mycopathologia       Date:  2009-05-08       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.